China · Biotechnology Research
Pharmaceuticals
Biotechnology
Healthcare
Biotechnology Research
Ascentage Pharma is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies and is in the process of conducting more than 40 clinical trials in specific regions worldwide. Ascentage Pharma has been listed on the Main Board of the HKEX with the stock code 6855.HK since October 2019 and recently listed in NASDAQ in January 2025 under the stock code AAPG.
2009
Founded
Biotechnology Research
Industry
China
Location
2,994,644
Ranking
200 employees
Size

Get full access to view complete information
